NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

全球消融技術市場(~2026):產品(無線電波/激光、超聲(ESWL、HIFU)、微波、電力)、應用(心血管/癌症/婦科/美容/疼痛管理)、用戶(醫院/門診中心)/醫療水療中心),按地區

Ablation Technology Market by Product (Radiofrequency, Laser, Ultrasound (ESWL,HIFU), Microwave, Electrical), Application (Cardiovascular, Cancer, Gynecological, Cosmetic, Pain Management), End User (Hospitals, ASC, Medical spas)-Global Forecast to 2026

出版商 MarketsandMarkets 商品編碼 1024374
出版日期 內容資訊 英文 222 Pages
訂單完成後即時交付
價格
全球消融技術市場(~2026):產品(無線電波/激光、超聲(ESWL、HIFU)、微波、電力)、應用(心血管/癌症/婦科/美容/疼痛管理)、用戶(醫院/門診中心)/醫療水療中心),按地區 Ablation Technology Market by Product (Radiofrequency, Laser, Ultrasound (ESWL,HIFU), Microwave, Electrical), Application (Cardiovascular, Cancer, Gynecological, Cosmetic, Pain Management), End User (Hospitals, ASC, Medical spas)-Global Forecast to 2026
出版日期: 2021年08月16日內容資訊: 英文 222 Pages
簡介

在預測期內,消融技術的市場規模預計將以 9.3% 的複合年增長率增長,從 2021 年的 52 億美元增長到 2026 年的 81 億美元。

由於老年人口的增加,目標疾病的發病率越來越高,對有效治療的需求越來越大。然而,發達國家的設備再利用和再加工以及不利的監管情況等因素是阻礙市場進一步增長的因素。

從應用來看,預計2020年心血管治療領域市場份額最大。疾病流行的增加和技術進步正在推動該行業的發展。從產品來看,射頻消融器部門預計在預測期內擁有最大份額。該部門的增長受到主要運營商推出新產品以及越來越多地採用射頻消融技術治療癌症、心臟病、眼科疾病等的推動。

本報告探討了全球消融技術市場,分析了市場定義和概述、價值鏈、新型冠狀病毒感染 (COVID-19) 和其他市場影響因素,以及監管和報銷環境。,市場規模轉變/預測,類型/產品/用途/最終用戶/地區/主要國家等,按類別、競爭環境、主要公司簡介等細分。

第 1 章介紹

第 2 章調查方法

第 3 章執行摘要

第 4 章重要考慮事項

第 5 章市場概覽

  • 市場動態
    • 促進因素
    • 抑制因素
    • 市場機會
    • 挑戰
  • 監管狀態
  • 價值鏈
  • 供應鏈
  • 生態範圍:母市場
  • 兌換場景
  • 價格趨勢
  • 貿易分析
  • 波特五力分析
  • COVID-19 的影響

第 6 章市場分析/預測:按類型

  • 無線電波燒灼
  • 雷射光/光燒灼
  • 超聲波燒灼
  • 電灼
  • 冷凍燒灼
  • 微波燒灼
  • 水熱/流體機械燒灼

第 7 章市場分析/預測:按產品

  • 無線電波消融器
    • 溫控電波消融器
    • 流體冷卻無線電波消融器
    • 機器人導管操作系統
  • 雷射光/光學燒蝕器
    • 準分子激光燒蝕機
    • 冷雷射光燒蝕機
  • 超聲波消融器
    • 超聲波手術消融系統
    • 高強度聚焦超聲消融器
    • 體外衝擊波碎石系統
    • 磁共振引導聚焦超聲消融器
  • 電動消融器
    • 氬等離子體/光束凝固法
    • 不可逆電外科鑽孔 (IRE) 消融器
  • 冷凍和燒灼裝置
    • 組織接觸探針
    • 組織噴霧探針
    • 表皮/皮下冷凍和燒灼裝置
  • 微波消融器
  • 水熱/流體機械燒蝕器

第 8 章市場分析/預測:按應用

  • 心血管疾病
  • 癌症
    • 肝癌
    • 腎癌
    • 前列腺癌
    • 肺癌
    • 骨轉移
    • 乳腺癌
  • 骨科
  • 整容手術/整容手術
  • 泌尿外科
  • 婦科
  • 疼痛管理
  • 眼科
  • 其他

第 9 章市場分析/預測:按最終用戶

  • 醫院/手術中心/消融中心
  • 門診手術中心
  • Medical Spa 美容診所
  • 其他

第 10 章市場分析/預測:按地區/主要國家

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第 11 章競爭形勢

  • 概述
  • 大公司的戰略
  • 收入份額分析
  • 市場份額分析
  • 企業評估象限
  • 企業評估象限(中小企業/初創公司)
  • 競爭基準
  • 競爭場景/趨勢

第 12 章公司簡介

  • 主要公司
    • MEDTRONIC
    • JOHNSON & JOHNSON
    • ABBOTT LABORATORIES
    • BOSTON SCIENTIFIC CORPORATION
    • ANGIODYNAMICS
    • ATRICURE
    • CONMED CORPORATION
    • OLYMPUS CORPORATION
    • SMITH & NEPHEW
    • STRYKER CORPORATION
    • DORNIER MEDTECH
    • CYNOSURE
    • VARIAN MEDICAL SYSTEMS
    • INMODE
  • 其他龍頭企業
    • EDAP TMS
    • LUMENIS
    • ARTHREX
    • ICECURE
    • MERIT MEDICAL

第 13 章附錄

目錄
Product Code: MD 2738

The ablation technology market is projected to reach USD 8.1 Billion by 2026 from USD 5.2 Billion in 2021, at a CAGR of 9.3% during the forecast period. The growing elderly population has also driven the incidence of target conditions and contributed to the demand for effective treatment. However, the reuse and reprocessing of devices in developed countries and unfavorable regulatory scenario are key factors limiting the growth of this market. Product recalls and therapeutic challenges related to the efficacy of ablation products are key challenges faced by industry players in the global ablation technology market.

In terms Application, the cardiovascular treatment segment is expected to account for the largest share of the ablation technology market in 2020."

Based on application, the ablation technology market is classified into major segments-cardiovascular disease treatment, cancer treatment, ophthalmological treatment, pain management, gynecological treatment, urological treatment, orthopedic treatment, cosmetic/aesthetic surgery, and other applications. Rising disease prevalence and technological advancement in this field will boost market growth.

"In terms of product segment, radiofrequency ablators segment is expected to account for the largest share during the forecast period."

Based on product, the global ablation technology market is classified into light/laser ablators, radiofrequency ablators, ultrasound ablators, electrical ablators, cryoablation devices, microwave ablators, and hydrothermal ablators/hydromechanical ablators. Each product class is further segmented based on its applications or source of energy.

The large share of radiofrequency ablators segment is attributed to the introduction of novel products by major market players and the increasing adoption of RF ablation technology to treat various conditions, such as cancer, cardiac diseases, and ophthalmic diseases.

"In terms of type segment, radiofrequency ablation segment is expected to account for the largest share during the forecast period."

Based on the type of energy source, the global ablation technology market is classified into light/laser, radiofrequency (RF), electrical, ultrasound, microwave, cryotherapy, and hydrothermal/hydromechanical ablation technologies. The lower cost of radiofrequency ablation, its ease of use, and the rising geriatric population fuel the growth of the radiofrequency ablation market.

"The hospitals, surgical centers, and ablation centers segment is expected to register the highest CAGR during the forecast period" `

The ablation technology market, by end user, is segmented into hospitals, surgical centers, and ablation centers, ambulatory surgical centers (ASCs), medical spas & aesthetic centers, and other end users. The increasing incidence of cancer, sports injuries, and cardiac conditions is driving the growth of the ablation technology market for hospitals, surgical centers, and ablation centers segment.

Asia Pacific market is expected to grow at the highest CAGR during the forecast period."

The ablation technology market covers five key geographies-North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2020, Asia Pacific region offered significant opportunities for the growth of the ablation technology market. The market growth in Asia Pacific can be attributed rising incidence and prevalence of cancer and cardiac conditions, technological advancement in ablation product and technology, increasing awareness of minimally invasive techniques and growth opportunities in the emerging markets.

A breakdown of the primary participants referred to for this report is provided below:

  • By Company Type: Tier 1-20%, Tier 2-45%, and Tier 3- 35%
  • By Designation: C-level-30%, Director-level-20%, and Others-50%
  • By Region: North America-36%, Europe-25%, Asia Pacific-27%, Latin America-9%, and the Middle East & Africa-3%

The prominent players in the ablation technology market include Medtronic, plc. (Ireland), Johnson & Johnson (US), Abbott (US), and Boston Scientific Corporation (US) and CONMED Corporation (US), AngioDynamics, Inc. (US), AtriCure, Inc. (US), Smith & Nephew plc (UK), Olympus Corporation (Japan), Varian Medical Systems (UK), Stryker (US), Dornier MedTech (Germany), Cynosure (US) and InMode (US).

Research Coverage

This report studies the ablation technology market based on type, product, application, end user, and region. It studies significant factors (such as drivers and restraints) affecting market growth. The report also analyzes opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. It explains micro markets with respect to their growth trends, prospects, and contributions to the total market. The report forecasts the revenue of the market segments with respect to five major regions and their respective major countries.

Reasons to Buy the Report

The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies for strengthening their market presence.

This report provides insights on the following pointers:

Market Penetration: Comprehensive information on the products offered by the top players in the ablation technology market

Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the ablation technology market

Market Development: Comprehensive information on lucrative emerging regions

Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in ablation technology market

Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS & EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 GEOGRAPHIC SCOPE
    • 1.3.3 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS
  • 1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 ABLATION TECHNOLOGY MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.1.1 SECONDARY RESEARCH
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY RESEARCH
    • FIGURE 2 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
    • FIGURE 3 BREAKDOWN OF SUPPLY-SIDE PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 TOTAL MARKET SIZE: ABLATION TECHNOLOGY MARKET
      • 2.2.1.1 Bottom-up approach
    • FIGURE 5 MARKET SIZE ESTIMATION: ABLATION TECHNOLOGY MARKET (BOTTOM-UP APPROACH)
      • 2.2.1.2 Growth forecast
    • FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.2.2 MARKET SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER)
    • FIGURE 7 TOP-DOWN APPROACH
    • 2.2.3 GEOGRAPHIC MARKET ASSESSMENT (BY REGION & COUNTRY)
    • 2.2.4 PRIMARY RESEARCH VALIDATION
  • 2.3 COVID-19 HEALTH ASSESSMENT
  • 2.4 COVID-19 ECONOMIC ASSESSMENT
  • 2.5 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
  • 2.6 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO IN THE ABLATION TECHNOLOGY MARKET
  • 2.7 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 10 ABLATION TECHNOLOGY MARKET: DATA TRIANGULATION METHODOLOGY
  • 2.8 RESEARCH ASSUMPTIONS AND LIMITATIONS
    • 2.8.1 ASSUMPTIONS FOR THE STUDY
  • 2.9 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: ABLATION TECHNOLOGY MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 11 ABLATION TECHNOLOGY MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION)
    • FIGURE 12 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2021 VS. 2026 (USD MILLION)
    • FIGURE 13 ABLATION TECHNOLOGY MARKET, BY END USER, 2021 VS. 2026 (USD MILLION)
    • FIGURE 14 ABLATION TECHNOLOGY MARKET, BY REGION, 2021 VS. 2026 (USD MILLION)

4 PREMIUM INSIGHTS

  • 4.1 ABLATION TECHNOLOGY MARKET OVERVIEW
    • FIGURE 15 EXPANSION OF THE TARGET POPULATION TO DRIVE MARKET GROWTH
  • 4.2 ABLATION TECHNOLOGY MARKET, BY PRODUCT
    • FIGURE 16 RADIOFREQUENCY ABLATORS WILL CONTINUE TO DOMINATE THE ABLATION TECHNOLOGY MARKET BY 2026
  • 4.3 ABLATION TECHNOLOGY MARKET, BY END USER
    • FIGURE 17 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS ARE THE LARGEST END USERS OF ABLATION TECHNOLOGY

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 18 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing demand for minimally invasive/non-invasive procedures
      • 5.2.1.2 The emergence of next-generation ablation products & technologies
      • 5.2.1.3 Expansion of the target patient population
        • 5.2.1.3.1 Rapid growth in the aging population with a higher risk of targeted diseases
    • TABLE 3 GERIATRIC POPULATION, BY REGION, 2015 VS 2030
        • 5.2.1.3.2 Growing incidence of sports injuries and cancer
        • 5.2.1.3.3 Growing prevalence of atrial fibrillation and other cardiac conditions
      • 5.2.1.4 The increasing number of hospitals and surgical & ablation centers
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Insufficient evidence and unfavorable regulatory scenario
      • 5.2.2.2 Strong market positioning of alternative therapies
    • TABLE 5 ALTERNATIVE THERAPIES/PROCEDURES TO ABLATION
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growth potential in emerging economies
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Product recalls
      • 5.2.4.2 Reuse and reprocessing of devices
      • 5.2.4.3 Therapeutic challenges and hazardous effects of ablation
  • 5.3 REGULATORY LANDSCAPE
    • TABLE 6 INDICATIVE LIST OF REGULATORY AUTHORITIES GOVERNING ABLATION DEVICES
    • 5.3.1 NORTH AMERICA
      • 5.3.1.1 US
    • TABLE 7 US FDA: MEDICAL DEVICE CLASSIFICATION
    • TABLE 8 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
    • FIGURE 19 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
      • 5.3.1.2 Canada
    • FIGURE 20 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
    • 5.3.2 EUROPE
    • FIGURE 21 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
    • 5.3.3 ASIA PACIFIC
      • 5.3.3.1 Japan
    • TABLE 10 JAPAN: PMDA CLASSIFICATION OF ABLATION DEVICES
    • TABLE 11 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
      • 5.3.3.2 China
    • TABLE 12 CHINA: CLASSIFICATION OF MEDICAL DEVICES
      • 5.3.3.3 India
    • TABLE 13 INDIA: CDSCO CLASSIFICATION OF ABLATION DEVICES
  • 5.4 VALUE CHAIN ANALYSIS
    • FIGURE 22 VALUE CHAIN ANALYSIS OF THE ABLATION TECHNOLOGY MARKET
  • 5.5 SUPPLY CHAIN ANALYSIS
    • TABLE 14 SUPPLY CHAIN ECOSYSTEM
  • 5.6 ECOSYSTEM COVERAGE: PARENT MARKET
  • 5.7 REIMBURSEMENT SCENARIO
    • TABLE 15 MEDICAL REIMBURSEMENT CPT CODES FOR MICROWAVE AND RADIOFREQUENCY ABLATION PROCEDURES IN THE US (EFFECTIVE JANUARY 1, 2021)
  • 5.8 PRICING TREND ANALYSIS
  • 5.9 TRADE ANALYSIS
    • 5.9.1 TRADE ANALYSIS FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES
    • TABLE 16 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SCIENCES, BY COUNTRY, 2016-2020 (USD BILLION)
  • 5.10 PORTER'S FIVE FORCE ANALYSIS
    • TABLE 17 ABLATION TECHNOLOGY MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.10.1 THREAT FROM NEW ENTRANTS
    • 5.10.2 THREAT OF SUBSTITUTES
    • 5.10.3 BARGAINING POWER OF SUPPLIERS
    • 5.10.4 BARGAINING POWER OF BUYERS
    • 5.10.5 INTENSITY OF COMPETITIVE RIVALRY
  • 5.11 COVID-19 IMPACT ON THE ABLATION TECHNOLOGY MARKET

6 ABLATION TECHNOLOGY MARKET, BY TYPE

  • 6.1 INTRODUCTION
    • TABLE 18 ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 6.2 RADIOFREQUENCY ABLATION
    • 6.2.1 THE LOW COST OF RADIOFREQUENCY ABLATION CONTRIBUTES TO MARKET GROWTH
    • TABLE 19 RADIOFREQUENCY ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.3 LASER/LIGHT ABLATION
    • 6.3.1 HIGH EFFICACY AND SAFETY DRIVE THE ADOPTION OF LASER/LIGHT ABLATION
    • TABLE 20 LASER/LIGHT ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.4 ULTRASOUND ABLATION
    • 6.4.1 TECHNOLOGICAL ADVANCEMENTS IN THE ULTRASOUND ABLATION SEGMENT WILL BOOST MARKET GROWTH
    • TABLE 21 ULTRASOUND ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.5 ELECTRICAL ABLATION
    • 6.5.1 THE USE OF ELECTRICAL ABLATION TECHNOLOGY IN CARDIOVASCULAR AND CANCER CONDITIONS WILL BOOST MARKET GROWTH
    • TABLE 22 ELECTRICAL ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.6 CRYOABLATION
    • 6.6.1 INCREASING FOCUS ON COSMETIC SURGERY IS A KEY MARKET GROWTH DRIVER
    • TABLE 23 CRYOABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.7 MICROWAVE ABLATION
    • 6.7.1 ADVANTAGES OVER RF ABLATION WILL ENSURE DEMAND FOR MICROWAVE ABLATION
    • TABLE 24 MICROWAVE ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 6.8 HYDROTHERMAL/HYDROMECHANICAL ABLATION
    • 6.8.1 INCREASING USAGE IN GYNECOLOGY WILL HELP IN MARKET GROWTH
    • TABLE 25 HYDROTHERMAL/HYDROMECHANICAL ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)

7 ABLATION TECHNOLOGY MARKET, BY PRODUCT

  • 7.1 INTRODUCTION
    • TABLE 26 ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
  • 7.2 RADIOFREQUENCY ABLATORS
    • TABLE 27 RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 28 RADIOFREQUENCY ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.1 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS
      • 7.2.1.1 Clinical advantages of temperature-controlled RF ablators over traditional approaches are driving the market
    • TABLE 29 TEMPERATURE-CONTROLLED RADIOFREQUENCY ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.2 FLUID-COOLED RADIOFREQUENCY ABLATORS
      • 7.2.2.1 Better temperature control as compared to other traditional radiofrequency ablators
    • TABLE 30 FLUID-COOLED RADIOFREQUENCY ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.2.3 ROBOTIC CATHETER MANIPULATION SYSTEMS
      • 7.2.3.1 The effectiveness of remote catheter manipulators in AF will propel market growth
    • TABLE 31 ROBOTIC CATHETER MANIPULATION SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.3 LASER/LIGHT ABLATORS
    • TABLE 32 LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 33 LASER/LIGHT ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.3.1 EXCIMER LASER ABLATORS
      • 7.3.1.1 Increasing use of excimer laser ablators in ophthalmological applications is a key driver of the market
    • TABLE 34 EXCIMER LASER ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.3.2 COLD LASER ABLATORS
      • 7.3.2.1 Cold laser ablator treatment releases endorphins to support pain management
    • TABLE 35 COLD LASER ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.4 ULTRASOUND ABLATORS
    • TABLE 36 ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 37 ULTRASOUND ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.4.1 ULTRASONIC SURGICAL ABLATION SYSTEMS
      • 7.4.1.1 Ultrasonic surgical ablators dominate the ultrasound ablators market
    • TABLE 38 ULTRASONIC SURGICAL ABLATION SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.4.2 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS
      • 7.4.2.1 Low procedural times and reduced bleeding support product adoption
    • TABLE 39 HIGH-INTENSITY FOCUSED ULTRASOUND ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.4.3 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS
      • 7.4.3.1 Growing incidence of obesity and diabetes drive the market growth
    • TABLE 40 EXTRACORPOREAL SHOCKWAVE LITHOTRIPSY SYSTEMS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.4.4 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS
      • 7.4.4.1 A combination of techniques allows for high efficacy
    • TABLE 41 MAGNETIC RESONANCE-GUIDED FOCUSED ULTRASOUND ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.5 ELECTRICAL ABLATORS
    • TABLE 42 ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 43 ELECTRICAL ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.5.1 ARGON PLASMA/BEAM COAGULATORS
      • 7.5.1.1 Increasing preference for APC is a key driver of the market
    • TABLE 44 ARGON PLASMA/BEAM COAGULATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.5.2 IRREVERSIBLE ELECTROPORATION ABLATORS
      • 7.5.2.1 IRE provides selective targeting and better control
    • TABLE 45 IRREVERSIBLE ELECTROPORATION ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.6 CRYOABLATION DEVICES
    • TABLE 46 CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 47 CRYOABLATION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.6.1 TISSUE CONTACT PROBES
      • 7.6.1.1 The safety and effectiveness of tissue contact probes have driven their use
    • TABLE 48 TISSUE CONTACT PROBES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.6.2 TISSUE SPRAY PROBES
      • 7.6.2.1 The ability to treat surgically inoperable tumors is driving the use of spray probes
    • TABLE 49 TISSUE SPRAY PROBES MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.6.3 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES
      • 7.6.3.1 Anesthetic properties of epidermal & subcutaneous probes are supporting market growth
    • TABLE 50 EPIDERMAL & SUBCUTANEOUS CRYOABLATION DEVICES MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 7.7 MICROWAVE ABLATORS
    • TABLE 51 MICROWAVE ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.7.1 MICROWAVE THERMOTHERAPY DEVICES
  • 7.8 HYDROTHERMAL/HYDROMECHANICAL ABLATORS
    • TABLE 52 HYDROTHERMAL/HYDROMECHANICAL ABLATORS MARKET, BY REGION, 2019-2026 (USD MILLION)
    • 7.8.1 ENDOMETRIAL HYDROTHERMAL BALLOON ABLATION DEVICES

8 ABLATION TECHNOLOGY MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
    • TABLE 53 ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
  • 8.2 CARDIOVASCULAR DISEASE TREATMENT
    • 8.2.1 THE GROWTH OF THE TARGET PATIENT POPULATION WILL CONTINUE TO PROPEL THE DEMAND FOR CARDIAC ABLATION DEVICES
    • TABLE 54 ABLATION TECHNOLOGY MARKET FOR CARDIOVASCULAR DISEASE TREATMENT, BY REGION, 2019-2026 (USD MILLION)
  • 8.3 CANCER TREATMENT
    • 8.3.1 RISING PREVALENCE OF CANCER TO PROPEL MARKET GROWTH
    • TABLE 55 COUNTRY-WISE CANCER INCIDENCE PER MILLION POPULATION, 2015-2019
    • 8.3.2 LIVER CANCER
    • 8.3.3 KIDNEY CANCER
    • 8.3.4 PROSTATE CANCER
    • 8.3.5 LUNG CANCER
    • 8.3.6 BONE METASTASIS
    • 8.3.7 BREAST CANCER
    • TABLE 56 ABLATION TECHNOLOGY MARKET FOR CANCER TREATMENT, BY REGION, 2019-2026 (USD MILLION)
  • 8.4 ORTHOPEDIC TREATMENT
    • 8.4.1 GROWING DISEASE PREVALENCE AND RISING GERIATRIC POPULATION DRIVE DEMAND FOR ABLATION IN ORTHOPEDIC TREATMENT
    • TABLE 57 ABLATION TECHNOLOGY MARKET FOR ORTHOPEDIC TREATMENT, BY REGION, 2019-2026 (USD MILLION)
  • 8.5 COSMETIC/AESTHETIC SURGERY
    • 8.5.1 COSMETIC/AESTHETIC SURGERY TO SEE HIGH GROWTH IN THE COMING YEARS
    • TABLE 58 ABLATION TECHNOLOGY MARKET FOR COSMETIC/AESTHETIC SURGERY, BY REGION, 2019-2026 (USD MILLION)
  • 8.6 UROLOGICAL TREATMENT
    • 8.6.1 THE HIGH PREVALENCE OF KIDNEY STONES IS A PROMINENT DRIVER OF MARKET GROWTH
    • TABLE 59 ABLATION TECHNOLOGY MARKET FOR UROLOGICAL TREATMENT, BY REGION, 2019-2026 (USD MILLION)
  • 8.7 GYNECOLOGICAL TREATMENT
    • 8.7.1 INCREASING PREVALENCE OF GYNECOLOGICAL CONDITIONS AND REPRODUCTIVE HEALTH CONCERNS TO BOOST MARKET GROWTH
    • TABLE 60 ABLATION TECHNOLOGY MARKET FOR GYNECOLOGICAL TREATMENT, BY REGION, 2019-2026 (USD MILLION)
  • 8.8 PAIN MANAGEMENT
    • 8.8.1 RISING DEMAND OF MIS TO HELP SUSTAIN MARKET GROWTH
    • TABLE 61 ABLATION TECHNOLOGY MARKET FOR PAIN MANAGEMENT, BY REGION, 2019-2026 (USD MILLION)
  • 8.9 OPHTHALMOLOGICAL TREATMENT
    • 8.9.1 THE RISING PREVALENCE OF VISION DISORDERS AND GROWING POPULATION WILL DRIVE THE MARKET GROWTH
    • TABLE 62 ABLATION TECHNOLOGY MARKET FOR OPHTHALMOLOGICAL TREATMENT, BY REGION, 2019-2026 (USD MILLION)
  • 8.10 OTHER APPLICATIONS
    • TABLE 63 ABLATION TECHNOLOGY MARKET FOR OTHER APPLICATIONS, BY REGION, 2019-2026 (USD MILLION)

9 ABLATION TECHNOLOGY MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 64 ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
  • 9.2 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS
    • 9.2.1 HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS ARE THE MAJOR END USERS OF THE MARKET
    • TABLE 65 ABLATION TECHNOLOGY MARKET FOR HOSPITALS, SURGICAL CENTERS, AND ABLATION CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 9.3 AMBULATORY SURGICAL CENTERS
    • 9.3.1 PATIENTS ARE INCREASINGLY OPTING FOR AMBULATORY CARE AS A MORE CONVENIENT ALTERNATIVE TO HOSPITAL-BASED OUTPATIENT PROCEDURES
    • TABLE 66 NUMBER OF MEDICARE-CERTIFIED ASCS IN THE US (2013-2018)
    • TABLE 67 ABLATION TECHNOLOGY MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2026 (USD MILLION)
  • 9.4 MEDICAL SPAS & AESTHETIC CLINICS
    • 9.4.1 MEDICAL SPAS & AESTHETIC CLINICS OFFER ABLATION SERVICES FOR ENHANCING THE BEAUTY AND OVERALL WELLNESS OF THE BODY
    • TABLE 68 ABLATION TECHNOLOGY MARKET FOR MEDICAL SPAS & AESTHETIC CLINICS, BY REGION, 2019-2026 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 69 ABLATION TECHNOLOGY MARKET FOR OTHER END USERS, BY REGION, 2019-2026 (USD MILLION)

10 ABLATION TECHNOLOGY MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 70 ABLATION TECHNOLOGY MARKET, BY REGION, 2019-2026 (USD MILLION)
  • 10.2 NORTH AMERICA
    • FIGURE 23 NORTH AMERICA: ABLATION TECHNOLOGY MARKET SNAPSHOT
    • TABLE 71 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 72 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 73 NORTH AMERICA: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 74 NORTH AMERICA: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 75 NORTH AMERICA: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 76 NORTH AMERICA: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 77 NORTH AMERICA: CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 78 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 79 NORTH AMERICA: ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.2.1 US
      • 10.2.1.1 The rising prevalence of cancer and CVD will propel market growth
    • TABLE 80 US: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.2.2 CANADA
      • 10.2.2.1 The high burden of cancer supports market growth
    • TABLE 81 CANADA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.3 EUROPE
    • TABLE 82 EUROPE: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 83 EUROPE: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 84 EUROPE: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 85 EUROPE: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 86 EUROPE: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 87 EUROPE: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 88 EUROPE: CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 89 EUROPE: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 90 EUROPE: ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.3.1 GERMANY
      • 10.3.1.1 Highly developed healthcare infrastructure and rising disease incidence ensure strong growth prospects
    • TABLE 91 GERMANY: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.2 FRANCE
      • 10.3.2.1 Growing geriatric population to support market growth in France
    • TABLE 92 FRANCE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION
    • 10.3.3 UK
      • 10.3.3.1 Rising geriatric population is supporting the market growth in the UK
    • TABLE 93 UK: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.4 ITALY
      • 10.3.4.1 Rising awareness to support market growth
    • TABLE 94 ITALY: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.5 SPAIN
      • 10.3.5.1 Increasing government funding for research to support market growth
    • TABLE 95 SPAIN: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.3.6 REST OF EUROPE
    • TABLE 96 ROE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • FIGURE 24 ASIA PACIFIC: ABLATION TECHNOLOGY MARKET SNAPSHOT
    • TABLE 97 APAC: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 98 APAC: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 99 APAC: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 100 APAC: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 101 APAC: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 102 APAC: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 103 APAC: CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 104 APAC: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 105 APAC: ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.4.1 JAPAN
      • 10.4.1.1 Presence of universal healthcare reimbursement scenario and growing geriatric population-key factors driving market growth
    • TABLE 106 JAPAN: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 Increasing patient pool and government initiatives for healthcare development are fueling the market growth
    • TABLE 107 CHINA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.4.3 INDIA
      • 10.4.3.1 Ongoing modernization and infrastructure development in India to support the market growth
    • TABLE 108 INDIA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.4.4 AUSTRALIA
      • 10.4.4.1 Rising research investments and awareness campaigns are the key factors supporting market growth
    • TABLE 109 AUSTRALIA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.4.5 SOUTH KOREA
      • 10.4.5.1 Rising R&D and promising clinical trials in the country to positively impact market growth
    • TABLE 110 SOUTH KOREA: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 111 ROAPAC: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.5 LATIN AMERICA
    • TABLE 112 LATAM: ABLATION TECHNOLOGY MARKET, BY COUNTRY, 2019-2026 (USD MILLION)
    • TABLE 113 LATAM: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 114 LATAM: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 115 LATAM: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 116 LATAM: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 117 LATAM: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 118 LATAM: CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 119 LATAM: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 120 LATAM: ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)
    • 10.5.1 BRAZIL
      • 10.5.1.1 Brazil is a key market in Latin America owing to the modernization of healthcare facilities
    • TABLE 121 BRAZIL: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.5.2 MEXICO
      • 10.5.2.1 Availability of advanced care and increasing awareness programs are fueling market growth in Mexico
    • TABLE 122 MEXICO: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • 10.5.3 REST OF LATIN AMERICA
    • TABLE 123 ROE: ABLATION TECHNOLOGY MARKET, BY TYPE, 2019-2026 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 IMPROVING HEALTHCARE INFRASTRUCTURE AND INCREASING PUBLIC-PRIVATE INVESTMENTS TO DRIVE MARKET GROWTH IN THE MEA
    • TABLE 124 MEA: ABLATION TECHNOLOGY MARKET, BY PRODUCT, 2019-2026 (USD MILLION)
    • TABLE 125 MEA: RADIOFREQUENCY ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 126 MEA: LASER/LIGHT ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 127 MEA: ULTRASOUND ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 128 MEA: ELECTRICAL ABLATORS MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 129 MEA: CRYOABLATION DEVICES MARKET, BY TYPE, 2019-2026 (USD MILLION)
    • TABLE 130 MEA: ABLATION TECHNOLOGY MARKET, BY APPLICATION, 2019-2026 (USD MILLION)
    • TABLE 131 MEA: ABLATION TECHNOLOGY MARKET, BY END USER, 2019-2026 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • FIGURE 25 OVERVIEW OF STRATEGIES ADOPTED BY KEY ABLATION TECHNOLOGY PROVIDERS
  • 11.3 REVENUE SHARE ANALYSIS
    • FIGURE 26 REVENUE SHARE ANALYSIS OF THE TOP PLAYERS IN THE ABLATION TECHNOLOGY MARKET
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 27 MEDTRONIC HELD THE LEADING POSITION IN THE ABLATION TECHNOLOGY MARKET IN 2020
    • TABLE 132 ABLATION TECHNOLOGY MARKET: DEGREE OF COMPETITION
  • 11.5 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
    • 11.5.1 STARS
    • 11.5.2 PERVASIVE PLAYERS
    • 11.5.3 EMERGING LEADERS
    • 11.5.4 PARTICIPANTS
    • FIGURE 28 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION QUADRANT, 2020
  • 11.6 COMPANY EVALUATION QUADRANT (SMES/START-UPS)
    • 11.6.1 PROGRESSIVE COMPANIES
    • 11.6.2 STARTING BLOCKS
    • 11.6.3 RESPONSIVE COMPANIES
    • 11.6.4 DYNAMIC COMPANIES
    • FIGURE 29 ABLATION TECHNOLOGY MARKET: COMPANY EVALUATION QUADRANT FOR SMES/START-UPS, 2020
  • 11.7 COMPETITIVE BENCHMARKING
    • FIGURE 30 PRODUCT AND REGIONAL FOOTPRINT ANALYSIS OF THE TOP PLAYERS IN THE ABLATION TECHNOLOGY MARKET
    • TABLE 133 COMPANY APPLICATION FOOTPRINT
    • TABLE 134 COMPANY REGIONAL FOOTPRINT
  • 11.8 COMPETITIVE SCENARIO AND TRENDS
    • 11.8.1 PRODUCT LAUNCHES & APPROVALS
    • 11.8.2 DEALS
    • 11.8.3 OTHER DEVELOPMENTS

12 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
  • 12.1 KEY PLAYERS
    • 12.1.1 MEDTRONIC
    • TABLE 135 MEDTRONIC: BUSINESS OVERVIEW
    • FIGURE 31 MEDTRONIC: COMPANY SNAPSHOT
    • TABLE 136 MEDTRONIC: PRODUCT OFFERINGS
    • 12.1.2 JOHNSON & JOHNSON
    • TABLE 137 JOHNSON & JOHNSON: BUSINESS OVERVIEW
    • FIGURE 32 JOHNSON & JOHNSON: COMPANY SNAPSHOT
    • TABLE 138 JOHNSON & JOHNSON: PRODUCT OFFERINGS
    • 12.1.3 ABBOTT LABORATORIES
    • TABLE 139 ABBOTT LABORATORIES: BUSINESS OVERVIEW
    • FIGURE 33 ABBOTT LABORATORIES: COMPANY SNAPSHOT
    • TABLE 140 ABBOTT LABORATORIES: PRODUCT OFFERINGS
    • 12.1.4 BOSTON SCIENTIFIC CORPORATION
    • TABLE 141 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
    • FIGURE 34 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
    • TABLE 142 BOSTON SCIENTIFIC CORPORATION: PRODUCT OFFERINGS
    • 12.1.5 ANGIODYNAMICS
    • TABLE 143 ANGIODYNAMICS: BUSINESS OVERVIEW
    • FIGURE 35 ANGIODYNAMICS: COMPANY SNAPSHOT
    • TABLE 144 ANGIODYNAMICS: PRODUCT OFFERINGS
    • 12.1.6 ATRICURE
    • TABLE 145 ATRICURE: BUSINESS OVERVIEW
    • FIGURE 36 ATRICURE: COMPANY SNAPSHOT
    • TABLE 146 ATRICURE: PRODUCT OFFERINGS
    • 12.1.7 CONMED CORPORATION
    • TABLE 147 CONMED: BUSINESS OVERVIEW
    • FIGURE 37 CONMED CORPORATION: COMPANY SNAPSHOT
    • TABLE 148 CONMED: PRODUCT OFFERINGS
    • 12.1.8 OLYMPUS CORPORATION
    • TABLE 149 OLYMPUS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 38 OLYMPUS CORPORATION: COMPANY SNAPSHOT
    • TABLE 150 OLYMPUS CORPORATION: PRODUCT OFFERINGS
    • 12.1.9 SMITH & NEPHEW
    • TABLE 151 SMITH & NEPHEW: BUSINESS OVERVIEW
    • FIGURE 39 SMITH & NEPHEW: COMPANY SNAPSHOT
    • TABLE 152 SMITH & NEPHEW: PRODUCT OFFERINGS
    • 12.1.10 STRYKER CORPORATION
    • TABLE 153 STRYKER: BUSINESS OVERVIEW
    • FIGURE 40 STRYKER CORPORATION: COMPANY SNAPSHOT
    • TABLE 154 STRYKER: PRODUCT OFFERINGS
    • 12.1.11 DORNIER MEDTECH
    • TABLE 155 DORNIER MEDTECH: BUSINESS OVERVIEW
    • TABLE 156 DORNIER MEDTECH: PRODUCT OFFERINGS
    • 12.1.12 CYNOSURE
    • TABLE 157 CYNOSURE: BUSINESS OVERVIEW
    • TABLE 158 CYNOSURE: PRODUCT OFFERINGS
    • 12.1.13 VARIAN MEDICAL SYSTEMS
    • TABLE 159 VARIAN MEDICAL SYSTEMS: BUSINESS OVERVIEW
    • FIGURE 41 VARIAN MEDICAL SYSTEMS.: COMPANY SNAPSHOT
    • TABLE 160 VARIAN MEDICAL SYSTEMS: PRODUCT OFFERINGS
    • 12.1.14 INMODE
    • TABLE 161 INMODE: BUSINESS OVERVIEW
    • FIGURE 42 INMODE: COMPANY SNAPSHOT
    • TABLE 162 INMODE: PRODUCT OFFERINGS
  • 12.2 OTHER COMPANIES
    • 12.2.1 EDAP TMS
    • 12.2.2 LUMENIS
    • 12.2.3 ARTHREX
    • 12.2.4 ICECURE
    • 12.2.5 MERIT MEDICAL
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 AVAILABLE CUSTOMIZATIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS